Related Experiment Video
Updated: Feb 18, 2026

Dual Immunofluorescence of γH2AX and 53BP1 in Human Peripheral Lymphocytes
Published on: July 14, 2023
HMGB1 interacts with XPA to facilitate the processing of DNA interstrand crosslinks in human cells
Anirban Mukherjee1, Karen M Vasquez2
1Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Pediatric Research Institute, 1400 Barbara Jordan Boulevard, Austin, TX 78723, USA.
Abstract:
Many effective agents used in cancer chemotherapy cause DNA interstrand crosslinks (ICLs), which covalently link both strands of the double helix together resulting in cytotoxicity. ICLs are thought to be processed by proteins from a variety of DNA repair pathways; however, a clear understanding of ICL recognition and repair processing in human cells is lacking. Previously, we found that the high mobility group box 1 (HMGB1) protein bound to triplex-directed psoralen ICLs (TFO-ICLs) in vitro, cooperatively with NER damage recognition proteins, promoted removal of UVC-induced lesions and facilitated error-free repair of TFO-ICLs in mouse fibroblasts. Here, we demonstrate that HMGB1 recognizes TFO-ICLs in human cells, and its depletion increases ICL-induced mutagenesis in human cells without altering the mutation spectra. In contrast, HMGB1 depletion in XPA-deficient human cells significantly altered the ICL-induced mutation spectrum from predominantly T→A to T→G transversions. Moreover, the recruitment of XPA and HMGB1 to the ICLs is co-dependent. Finally, we show that HMGB1 specifically introduces negative supercoils in ICL-containing plasmids in HeLa cell extracts. Taken together, our data suggest that in human cells, HMGB1 functions in association with XPA on ICLs and facilitates the formation of a favorable architectural environment for ICL repair processing.
Insights
High mobility group box 1 (HMGB1) aids DNA repair in human cells by recognizing DNA interstrand crosslinks (ICLs). HMGB1 works with XPA to promote accurate ICL repair, preventing harmful mutations during chemotherapy.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- DNA interstrand crosslinks (ICLs) are cytotoxic DNA lesions caused by chemotherapy agents.
- Understanding ICL recognition and repair in human cells is crucial but incomplete.
- Previous studies showed High Mobility Group Box 1 (HMGB1) aids ICL repair in mouse cells.
Purpose of the Study:
- To investigate the role of HMGB1 in recognizing and processing ICLs in human cells.
- To determine how HMGB1 influences ICL-induced mutagenesis and mutation spectra.
- To elucidate the interaction between HMGB1 and XPA in ICL repair.
Main Methods:
- Depletion of HMGB1 in human cells and analysis of ICL-induced mutations.
- Assessment of mutation spectra in HMGB1-depleted and XPA-deficient cells.
- Co-depletion experiments to study XPA and HMGB1 recruitment to ICLs.
- In vitro supercoiling assays using ICL-containing plasmids and HeLa cell extracts.
Main Results:
- HMGB1 depletion increased ICL-induced mutagenesis in human cells.
- HMGB1 depletion altered mutation spectra in XPA-deficient cells (T→A to T→G).
- XPA and HMGB1 recruitment to ICLs was found to be co-dependent.
- HMGB1 was shown to introduce negative supercoils into ICL-containing plasmids.
Conclusions:
- HMGB1 recognizes ICLs in human cells and functions with XPA.
- HMGB1 facilitates a favorable DNA structure for efficient ICL repair.
- HMGB1 plays a significant role in preventing mutagenesis during ICL repair processing.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Homologous Recombination
Fixing Double-strand Breaks
Long-patch Base Excision Repair
Single-Strand DNA Binding Proteins

